Inactive Instrument

Highlights MiMedx Group Inc Nasdaq

Equities

US6024961012

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

MiMedx Group Says FDA Affirms Axiofill Falls Short of Regulatory Standards for Tissue-Based Products	Mar. 27	MT
MiMedx Group, Inc. Provides Update on AXIOFILL Request for Designation from FDA	Mar. 27	CI
MiMedx Group to Buy Distribution Rights for TELA Bio's Wound Care Product	Mar. 20	MT
MiMedx Launches E-Commerce Platform	Mar. 13	MT
Mimedx Introduces E-Commerce and Account Management Platform	Mar. 13	CI
Spectral AI Names Peter Carlson Chief Executive Officer; Reaffirms 2024 Preliminary Revenue Guidance	Mar. 01	MT
Earnings Flash (MDXG) MIMEDX GROUP Posts Q4 Revenue $86.8M, vs. Street Est of $85.2M	Feb. 28	MT
Earnings Flash (MDXG) MIMEDX GROUP Reports Q4 EPS $0.04, vs. Street Est of $0.06	Feb. 28	MT
MiMedx Group, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 28	CI
MiMedx Group, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 28	CI
MiMedx reports US FDA warning letter for Axiofill, shares drop	Dec. 29	RE
Stocks to Watch : MiMedx Group, Nokia	Dec. 29	DJ
MiMedx says US FDA's warning letter for Axiofill not related to safety	Dec. 29	RE
MiMedx Group Swings to Q3 Profit, Revenue Rises; Shares Fall After Hours	23-10-30	MT
MiMedx Group, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-30	CI
Earnings Flash (MDXG) MIMEDX GROUP Reports Q3 Revenue $81.7M, vs. Street Est of $77.9M	23-10-30	MT
Earnings Flash (MDXG) MIMEDX GROUP Posts Q3 EPS $0.05, vs. Street Est of $0.05	23-10-30	MT
Mimedx Group, Inc. Announces Launch of Epieffect	23-09-26	CI
MediWound Ltd. Announces Collaboration with MIMEDX Group, Inc. on EscharEx® Phase III Study	23-08-15	CI
MiMedx Group, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-01	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights MiMedx Group Inc Nasdaq

Equities

US6024961012

Highlights

Filters